line divider


Our Blog

Latest News

Why Neurology Clinical Trial Protocols are So Complex–and How to Support Sites with StudyTeam

According to StudyTeam reports, neurology has one of the lower enrollment conversion rates relative to other therapeutic areas. As an example: For all of the neurology patient ...
Read More

3 Reasons We Need Tech to Speed Up Enrollment for Alzheimer's Disease Clinical Trials

By: Irene Meier, neuroscientist and senior lead for sponsor transformation at OneStudyTeam Clinical trials focused on Alzheimer’s disease treatment have been underway for nearly 45 ...
Read More

3 Ways Secure Data Sharing Can Accelerate ALS Clinical Trials

With the recent approval of Amylyx Pharmaceuticals’ drug Relyvrio, clinical trials for amyotrophic lateral sclerosis (ALS) are in the spotlight. Continual innovation is needed to ...
Read More

Overcoming Racial Disparities in GI Cancer: How StudyTeam’s Diversity Reporting Can Bridge Gaps

In the last several decades, public health research has illuminated the considerable racial and ethnic disparities in the diagnosis, treatment, and outcomes of many cancers. In ...
Read More

What is StudyTeam's Referral Partner Interface and Why Should Sponsors Care?

In this article, we will learn why Referral Partner Interface streamlines clinical trial enrollment, improves clinical trial referral ROI for sponsors, and provides sites with a ...
Read More

3 Major GI Clinical Trial Enrollment Challenges (and How to Address Them)

Roughly 40% of adults suffer from functional gastrointestinal (GI) disorders worldwide. However, despite the prevalence of GI conditions, clinical trials for GI treatments are ...
Read More
OST Transparent (1)